These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 7879053

  • 1. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C, Heemann U, Azuma H, Tilney NL.
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract] [Full Text] [Related]

  • 2. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC, Fisher RA, Cohen DS, Tawes JW, Grimes MM.
    J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
    [Abstract] [Full Text] [Related]

  • 3. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM, Kahan BD.
    Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract] [Full Text] [Related]

  • 4. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H, Wu J, Xu D, Luo H, Daloze P.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract] [Full Text] [Related]

  • 5. Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection.
    Ferraresso M, Wang ME, Stepkowski SM, Kahan BD.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):729. PubMed ID: 8438460
    [No Abstract] [Full Text] [Related]

  • 6. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y, Waer M.
    Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
    [No Abstract] [Full Text] [Related]

  • 7. Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model.
    Murphy MP, Morris RE.
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):75-6. PubMed ID: 7685955
    [No Abstract] [Full Text] [Related]

  • 8. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T, Stepkowski SM, Smith S, Kahan BD.
    Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM, Tu Y, Chou TC, Kahan BD.
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract] [Full Text] [Related]

  • 10. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F, Shen J, Chong A, Liu W, Foster P, Blinder HL, Sankary H, McChesney L, Mital D, Williams JW.
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract] [Full Text] [Related]

  • 11. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
    Morris RE, Huang X, Gregory CR, Billingham ME, Rowan R, Shorthouse R, Berry GJ.
    Transplant Proc; 1995 Jun; 27(3):2068-9. PubMed ID: 7792888
    [No Abstract] [Full Text] [Related]

  • 12. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
    Chen H, Wu J, Luo H, Daloze P.
    Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
    [No Abstract] [Full Text] [Related]

  • 13. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 14. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
    Morris RE, Wu J, Shorthouse R.
    Transplant Proc; 1990 Aug 18; 22(4):1638-41. PubMed ID: 1697111
    [No Abstract] [Full Text] [Related]

  • 15. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.
    Aziz S, Tada Y, Gordon D, McDonald TO, Fareed J, Verrier ED.
    J Heart Lung Transplant; 1993 Aug 18; 12(4):634-43. PubMed ID: 8396435
    [Abstract] [Full Text] [Related]

  • 16. Rapamycin and cyclosporine A treatment: a novel regimen to prevent chronic allograft rejection in sensitized hosts.
    Wasowska B, Hancock WW, Onodera K, Korom S, Stadlbauer TH, Zheng XX, Strom TB, Kupiec-Weglinski JW.
    Transplant Proc; 1997 Aug 18; 29(1-2):333. PubMed ID: 9123026
    [No Abstract] [Full Text] [Related]

  • 17. The influence of antigen-dependent and antigen-independent factors on the development of graft vasculopathy in a fully allogeneic cardiac allograft model in the rat.
    Fiedel S, Bayer J, Schaub M, Heidt MC, Grebe M, Tillmanns H, Stadlbauer TH.
    Transplant Proc; 2009 Aug 18; 41(6):2625-7. PubMed ID: 19715988
    [Abstract] [Full Text] [Related]

  • 18. Reversal of ongoing rejection of allografts by rapamycin.
    Chen HF, Wu JP, Luo HY, Daloze PM.
    Transplant Proc; 1991 Aug 18; 23(4):2241-2. PubMed ID: 1871859
    [No Abstract] [Full Text] [Related]

  • 19. Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection.
    Thompson P, Xu D, Brunette I, Chen H.
    Transplant Proc; 1998 Jun 18; 30(4):1033-5. PubMed ID: 9636417
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of rapamycin in orthotopic small bowel transplantation in the rat.
    Marquet RL, de Bruin RW, Heineman E, Jeekel J.
    Transplant Proc; 1993 Aug 18; 25(4):2695-6. PubMed ID: 8356718
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.